SummaryAn enormous amount of molecular and phenotypic information of drugs as well as diseases is now available in public repositories. Computational analysis of these datasets is facilitating the acquisition of a systems view of how drugs act on our human organism and interfere with diseases. Here, I highlight recent approaches integrating large-scale information of drugs and diseases that are contributing to change our current view on how drugs interfere with human diseases
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks ...
The study of molecular networks has recently moved into the limelight of biomedical research. While ...
"Big" molecules such as proteins and genes still continue to capture the imagination of most biologi...
SummaryAn enormous amount of molecular and phenotypic information of drugs as well as diseases is no...
An enormous amount of molecular and phenotypic information of drugs as well as diseases is now avail...
An enormous amount of molecular and phenotypic information of drugs as well as diseases is now avail...
Efforts to compile the phenotypic effects of drugs and environmental chemicals offer the opportunity...
The failure of biology to identify the molecular causes of disease has led to disappointment in the ...
AbstractSystems biology aims to provide a holistic and in many cases dynamic picture of biological f...
Advances in science and technology have substantially changed drug research and development (R&D) pr...
Genome-Wide Association Studies (GWAS), whole genome sequencing, and high-throughput omics technique...
The increased availability of large-scale open-access resources on bioactivities of small molecules ...
The Human Genome Project and the explosion of high-throughput data have transformed the areas of mol...
Background Microbes are associated with many human diseases and influence drug efficacy. Small-molec...
Biomedical discovery has been reshaped upon the exploding digitization of data which can be retrieve...
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks ...
The study of molecular networks has recently moved into the limelight of biomedical research. While ...
"Big" molecules such as proteins and genes still continue to capture the imagination of most biologi...
SummaryAn enormous amount of molecular and phenotypic information of drugs as well as diseases is no...
An enormous amount of molecular and phenotypic information of drugs as well as diseases is now avail...
An enormous amount of molecular and phenotypic information of drugs as well as diseases is now avail...
Efforts to compile the phenotypic effects of drugs and environmental chemicals offer the opportunity...
The failure of biology to identify the molecular causes of disease has led to disappointment in the ...
AbstractSystems biology aims to provide a holistic and in many cases dynamic picture of biological f...
Advances in science and technology have substantially changed drug research and development (R&D) pr...
Genome-Wide Association Studies (GWAS), whole genome sequencing, and high-throughput omics technique...
The increased availability of large-scale open-access resources on bioactivities of small molecules ...
The Human Genome Project and the explosion of high-throughput data have transformed the areas of mol...
Background Microbes are associated with many human diseases and influence drug efficacy. Small-molec...
Biomedical discovery has been reshaped upon the exploding digitization of data which can be retrieve...
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks ...
The study of molecular networks has recently moved into the limelight of biomedical research. While ...
"Big" molecules such as proteins and genes still continue to capture the imagination of most biologi...